Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01074320 · ClinicalTrials.gov registry record
Measuring Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors
A clinical trial, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 150
- Enrollment target
NCT01074320 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 150 participants.
The verdict
NCT01074320 has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Current guidelines recommend endocrine treatment with aromatase inhibitors (AIs) in post-menopausal women with hormone receptor-positive breast cancer. Musculoskeletal symptoms are commonly reported with AI treatment,however, we do not have consistent methods to measure these symptoms prospectively. This gap in our knowledge inhibits the ability to test and develop treatments for AI-associated musculoskeletal symptoms. This pilot study will evaluate functional tests and standardized instruments for their ability to prospectively assess musculoskeletal symptoms in women being treated with AIs for breast cancer.
Interventions
- OTHER Other
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2010-02 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01074320
The ClinicalTrials.gov registry entry for NCT01074320 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Other is the first listed.
NCT01074320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01074320 about?
NCT01074320 is a clinical study titled "Measuring Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors". Current guidelines recommend endocrine treatment with aromatase inhibitors (AIs) in post-menopausal women with hormone receptor-positive breast cancer. Musculoskeletal symptoms are commonly reported with AI treatment,however, we do not have consistent methods to measure these symptoms prospectively....
What is the current status of trial NCT01074320?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2010-02. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01074320?
The interventions under investigation include: Other (OTHER).
Who is sponsoring clinical trial NCT01074320?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.